Predictors of persistent high disease activity after methotrexate treatment in rheumatoid arthritis patients. Universa Medicina, [S. l.], v. 44, n. 2, p. 141–151, 2025. DOI: 10.18051/UnivMed.2025.v44.141-151. Disponível em: https://univmed.org/ejurnal/index.php/medicina/article/view/1754. Acesso em: 29 jul. 2025.